MD Biosciences Releases Lumican and Keratocan Monoclonal Antibodies for Eye/Cornea Research

Published: Dec 09, 2008

ST PAUL, Minn.--(BUSINESS WIRE)--MD Biosciences, a global biotechnology company focused in inflammations and neurology research, announces the launch of Lumican and Keratocan Monoclonal Antibodies. Both Lumican and Keratocan play a role in the development and maintenance of corneal transparency making them ideal for applications in Eye and Cornea Research.

Back to news